000 01242 a2200349 4500
005 20250513203003.0
264 0 _c20000217
008 200002s 0 0 eng d
022 _a0309-0167
024 7 _a10.1046/j.1365-2559.2000.0823c.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJessop, F A
245 0 0 _aMüllerian adenosarcoma of the uterus in association with tamoxifen therapy.
_h[electronic resource]
260 _bHistopathology
_cJan 2000
300 _a91-2 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdenosarcoma
_xchemically induced
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents, Hormonal
_xadverse effects
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCarcinoma, Ductal, Breast
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMullerian Ducts
_xchemistry
650 0 4 _aTamoxifen
_xadverse effects
650 0 4 _aUterine Neoplasms
_xchemically induced
700 1 _aRoberts, P F
773 0 _tHistopathology
_gvol. 36
_gno. 1
_gp. 91-2
856 4 0 _uhttps://doi.org/10.1046/j.1365-2559.2000.0823c.x
_zAvailable from publisher's website
999 _c10635483
_d10635483